Unravelling the synthetic and therapeutic aspects of five, six and fused heterocycles using Vilsmeier-Haack reagent

The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier-Haack (V. H.) reagent. These derivatives act as excellent precursors having different aryl ring functionalities and could be used for the synthesis of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:RSC advances Jg. 13; H. 38; S. 2664 - 26629
Hauptverfasser: Chahal, Mamta, Dhillon, Sudeep, Rani, Priyanka, Kumari, Ginna, Aneja, Deepak Kumar, Kinger, Mayank
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Cambridge Royal Society of Chemistry 05.09.2023
The Royal Society of Chemistry
Schlagworte:
Anticonvulsants
Chemical synthesis
Chemistry
Heterocyclic compounds
Organic chemistry
Precursors
Reagents
ISSN:2046-2069, 2046-2069
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier-Haack (V. H.) reagent. These derivatives act as excellent precursors having different aryl ring functionalities and could be used for the synthesis of a variety of heterocyclic scaffolds. The V. H. reagent, a versatile reagent in organic chemistry, is used to formylate various heterocyclic compounds of medicinal interest. Due to the different chemical interactions, efficacy, and potency of V. H. reagents, plenty of heterocyclic compounds can be synthesized which serve as a constituent in various novel medications and acts as a bridge between biology and chemistry. These carboxylate moieties can effectively cooperate as precursors for several multi-component reactions (MCR) including Strecker synthesis, Bucherer-Berg reaction and post-MCR cyclization, modified variants with various pharmaceutical applications such as anti-tumor, anti-convulsant, anti-chitosomal and so on. The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier-Haack (V. H.) reagent.
AbstractList The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier-Haack (V. H.) reagent. These derivatives act as excellent precursors having different aryl ring functionalities and could be used for the synthesis of a variety of heterocyclic scaffolds. The V. H. reagent, a versatile reagent in organic chemistry, is used to formylate various heterocyclic compounds of medicinal interest. Due to the different chemical interactions, efficacy, and potency of V. H. reagents, plenty of heterocyclic compounds can be synthesized which serve as a constituent in various novel medications and acts as a bridge between biology and chemistry. These carboxylate moieties can effectively cooperate as precursors for several multi-component reactions (MCR) including Strecker synthesis, Bucherer-Berg reaction and post-MCR cyclization, modified variants with various pharmaceutical applications such as anti-tumor, anti-convulsant, anti-chitosomal and so on. The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier-Haack (V. H.) reagent.
The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier–Haack (V. H.) reagent. These derivatives act as excellent precursors having different aryl ring functionalities and could be used for the synthesis of a variety of heterocyclic scaffolds. The V. H. reagent, a versatile reagent in organic chemistry, is used to formylate various heterocyclic compounds of medicinal interest. Due to the different chemical interactions, efficacy, and potency of V. H. reagents, plenty of heterocyclic compounds can be synthesized which serve as a constituent in various novel medications and acts as a bridge between biology and chemistry. These carboxylate moieties can effectively cooperate as precursors for several multi-component reactions (MCR) including Strecker synthesis, Bucherer–Berg reaction and post-MCR cyclization, modified variants with various pharmaceutical applications such as anti-tumor, anti-convulsant, anti-chitosomal and so on.
The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier–Haack (V. H.) reagent. These derivatives act as excellent precursors having different aryl ring functionalities and could be used for the synthesis of a variety of heterocyclic scaffolds. The V. H. reagent, a versatile reagent in organic chemistry, is used to formylate various heterocyclic compounds of medicinal interest. Due to the different chemical interactions, efficacy, and potency of V. H. reagents, plenty of heterocyclic compounds can be synthesized which serve as a constituent in various novel medications and acts as a bridge between biology and chemistry. These carboxylate moieties can effectively cooperate as precursors for several multi-component reactions (MCR) including Strecker synthesis, Bucherer–Berg reaction and post-MCR cyclization, modified variants with various pharmaceutical applications such as anti-tumor, anti-convulsant, anti-chitosomal and so on. The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier–Haack (V. H.) reagent.
The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier-Haack (V. H.) reagent. These derivatives act as excellent precursors having different aryl ring functionalities and could be used for the synthesis of a variety of heterocyclic scaffolds. The V. H. reagent, a versatile reagent in organic chemistry, is used to formylate various heterocyclic compounds of medicinal interest. Due to the different chemical interactions, efficacy, and potency of V. H. reagents, plenty of heterocyclic compounds can be synthesized which serve as a constituent in various novel medications and acts as a bridge between biology and chemistry. These carboxylate moieties can effectively cooperate as precursors for several multi-component reactions (MCR) including Strecker synthesis, Bucherer-Berg reaction and post-MCR cyclization, modified variants with various pharmaceutical applications such as anti-tumor, anti-convulsant, anti-chitosomal and so on.The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier-Haack (V. H.) reagent. These derivatives act as excellent precursors having different aryl ring functionalities and could be used for the synthesis of a variety of heterocyclic scaffolds. The V. H. reagent, a versatile reagent in organic chemistry, is used to formylate various heterocyclic compounds of medicinal interest. Due to the different chemical interactions, efficacy, and potency of V. H. reagents, plenty of heterocyclic compounds can be synthesized which serve as a constituent in various novel medications and acts as a bridge between biology and chemistry. These carboxylate moieties can effectively cooperate as precursors for several multi-component reactions (MCR) including Strecker synthesis, Bucherer-Berg reaction and post-MCR cyclization, modified variants with various pharmaceutical applications such as anti-tumor, anti-convulsant, anti-chitosomal and so on.
Author Kinger, Mayank
Chahal, Mamta
Rani, Priyanka
Kumari, Ginna
Aneja, Deepak Kumar
Dhillon, Sudeep
AuthorAffiliation Department of Chemistry
Chaudhary Bansi Lal University
AuthorAffiliation_xml – sequence: 0
  name: Department of Chemistry
– sequence: 0
  name: Chaudhary Bansi Lal University
Author_xml – sequence: 1
  givenname: Mamta
  surname: Chahal
  fullname: Chahal, Mamta
– sequence: 2
  givenname: Sudeep
  surname: Dhillon
  fullname: Dhillon, Sudeep
– sequence: 3
  givenname: Priyanka
  surname: Rani
  fullname: Rani, Priyanka
– sequence: 4
  givenname: Ginna
  surname: Kumari
  fullname: Kumari, Ginna
– sequence: 5
  givenname: Deepak Kumar
  surname: Aneja
  fullname: Aneja, Deepak Kumar
– sequence: 6
  givenname: Mayank
  surname: Kinger
  fullname: Kinger, Mayank
BookMark eNptkttrFDEUxoNUsNa--C4EfBFxNPedPEmp1goFQayv4WzmzDZ1NlmTmcX9783s1lsxLyeX3_ednJw8JkcxRSTkKWevOZP2TSczMCWZ7R-QY8GUaQQz9uiv-SNyWsotq8NoLgw_JuU6ZtjiMIS4ouMN0rKLNYzBU4jdvJNhg9N-XTbox0JTT_uwxVe0hB97qJ8KdrSKMCe_8wMWOpXZ72sYyhoD5uYSwH-jGWGFcXxCHvYwFDy9iyfk-uL9l_PL5urTh4_nZ1eNV8yMDdjOLgVai6JbYKs5Q-UNLoFZtIYvvPDGLIVphYFWI_OqBQBtVGdBWejkCXl78N1MyzV2vqbOMLhNDmvIO5cguH9PYrhxq7R1nKlFq5muDi_uHHL6PmEZ3ToUX18LIqapONEaIRjTTFb0-T30Nk051vpmSirJteaVYgfK51RKxt75MMIY0nyBMNTMbm6leyc_n-1beVElL-9JfhXwX_jZAc7F_-b-_Av5ExslrPI
CitedBy_id crossref_primary_10_1021_acs_joc_5c01385
crossref_primary_10_3390_M1782
crossref_primary_10_1002_ajoc_202500517
crossref_primary_10_1016_j_tet_2024_133866
crossref_primary_10_3390_M1979
crossref_primary_10_1002_bkcs_70022
crossref_primary_10_1016_j_jscs_2024_101884
crossref_primary_10_1002_ajoc_202400588
Cites_doi 10.1007/s10593-015-1789-z
10.1016/j.ejmech.2015.05.037
10.1248/cpb.51.838
10.1039/C6RA06093E
10.1007/s10534-011-9496-4
10.1002/ps.7349
10.2166/wst.2016.414
10.3998/ark.5550190.0007.b07
10.1055/s-0035-1561459
10.1080/00304948.2017.1342511
10.1002/ejoc.201800249
10.1002/jhet.3894
10.1134/S1070363218060099
10.1021/jm070528f
10.1038/nrd1034
10.1016/j.matpr.2018.06.560
10.1016/j.ejmech.2014.09.001
10.1016/j.bmc.2007.12.033
10.1080/00397910500290573
10.1016/j.molstruc.2018.11.030
10.1016/j.tet.2011.06.040
10.1007/s10965-021-02672-1
10.21833/ijaas.2021.06.015
10.1016/j.jsps.2012.03.002
10.1016/j.ejmech.2016.05.043
10.1016/j.jscs.2014.12.004
10.1246/cl.150133
10.1016/j.cdc.2022.100930
10.1007/s11164-016-2738-x
10.3390/M1136
10.1016/j.ejmech.2007.12.006
10.1002/bkcs.11673
10.3390/antibiotics9100650
10.1021/jo801492k
10.1021/jf100872f
10.1080/00397911.2014.994128
10.9734/ACSJ/2012/1063
10.1002/jhet.5570390503
10.1134/S1070363219060161
10.2174/138955707781662645
10.1016/j.tet.2008.03.038
10.1016/j.ejmech.2014.11.042
10.1016/j.ejmech.2016.12.059
10.1021/jm010032c
10.2298/JSC0607713C
10.1039/C0OB00771D
10.1002/cber.19270600118
10.1016/j.ejmech.2006.12.032
10.1002/1521-4184(200205)335:5<213::AID-ARDP213>3.0.CO;2-H
10.1134/S1070428019100087
10.1016/j.tetlet.2016.02.045
10.1016/j.tetlet.2010.03.117
10.1016/S0091-3057(84)80027-1
10.1002/jhet.338
10.3390/molecules26102907
10.4314/tjpr.v15i12.12
10.1016/j.bmcl.2015.11.038
10.1021/jm070821f
10.1016/B978-0-08-052349-1.00049-4
10.1002/jhet.3824
10.1021/jo101949y
10.1080/00397911.2020.1750033
10.1016/j.tetlet.2021.153297
10.1039/C8OB03040E
10.1002/jhet.3849
10.1016/j.crci.2017.12.001
10.3998/ark.5550190.0007.a17
10.1134/S0036024417020182
10.1002/jhet.1506
10.1134/S1070428017010110
10.3390/molecules25122758
10.1063/5.0093601
10.1248/cpb.52.307
10.1016/j.jksus.2022.102023
10.1155/2021/2408006
10.1016/j.ejmech.2017.04.002
10.1007/s11696-022-02066-7
10.1016/j.ejmech.2006.09.006
10.1007/s00706-020-02733-z
10.1021/jm060499t
10.1016/S0039-6257(99)00079-X
10.1134/S1070363217100280
10.1002/jhet.3282
10.1016/j.ejmech.2014.11.059
10.1055/s-0036-1588992
10.1007/s40843-017-9084-x
ContentType Journal Article
Copyright Copyright Royal Society of Chemistry 2023
This journal is © The Royal Society of Chemistry.
This journal is © The Royal Society of Chemistry 2023 The Royal Society of Chemistry
Copyright_xml – notice: Copyright Royal Society of Chemistry 2023
– notice: This journal is © The Royal Society of Chemistry.
– notice: This journal is © The Royal Society of Chemistry 2023 The Royal Society of Chemistry
DBID AAYXX
CITATION
7SR
8BQ
8FD
JG9
7X8
5PM
DOI 10.1039/d3ra04309f
DatabaseName CrossRef
Engineered Materials Abstracts
METADEX
Technology Research Database
Materials Research Database
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
Materials Research Database
Engineered Materials Abstracts
Technology Research Database
METADEX
MEDLINE - Academic
DatabaseTitleList
Materials Research Database

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 2046-2069
EndPage 26629
ExternalDocumentID PMC10478505
10_1039_D3RA04309F
d3ra04309f
GrantInformation_xml – fundername: ;
  grantid: 09/1307(16134)/2022-EMR-1
– fundername: ;
  grantid: 211610128270; 114/CSIR-UGC NET JUNE 2019
GroupedDBID -JG
0-7
0R~
53G
AAFWJ
AAHBH
AAIWI
AAJAE
AARTK
AAWGC
AAXHV
ABEMK
ABGFH
ABPDG
ABXOH
ACGFS
ADBBV
ADMRA
AEFDR
AENEX
AESAV
AFLYV
AFVBQ
AGEGJ
AGRSR
AGSTE
AHGCF
AKBGW
ALMA_UNASSIGNED_HOLDINGS
ANUXI
APEMP
ASKNT
AUDPV
BCNDV
BLAPV
BSQNT
C6K
EBS
EE0
EF-
GROUPED_DOAJ
H13
HZ~
H~N
J3I
M~E
O9-
OK1
PGMZT
R7C
R7G
RCNCU
RPM
RPMJG
RRC
RSCEA
RVUXY
SLH
SMJ
ZCN
AAYXX
ABIQK
AFPKN
AGMRB
CITATION
7SR
8BQ
8FD
JG9
7X8
5PM
ID FETCH-LOGICAL-c406t-a9d9b2e99e2d7e8510e4c6eba09e9617c2c66b26826a85e0c48aaa564d9a49ad3
ISICitedReferencesCount 16
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001058492700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2046-2069
IngestDate Tue Nov 04 02:06:35 EST 2025
Fri Sep 05 14:45:05 EDT 2025
Sun Jun 29 15:21:33 EDT 2025
Tue Nov 18 22:11:16 EST 2025
Sat Nov 29 06:30:22 EST 2025
Tue Dec 17 20:58:43 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 38
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c406t-a9d9b2e99e2d7e8510e4c6eba09e9617c2c66b26826a85e0c48aaa564d9a49ad3
Notes Mamta Chahal was born in Jind district, Haryana state, India. She obtained her Bachelor's degree in 2017 and master's degree in organic chemistry from Kurukshetra university, Kurukshetra in 2019. She is persuing her PhD degree with Dr Mayank Kinger, Associate professor, at Chaudhary Bansi Lal University, Haryana, India. Her research area is the synthetic utility of novel heterocycles.
Sudeep Dhillon was born and grew up in Dahola, Jind, Haryana, India. Sudeep Dhillon obtained his bachelor's degree in Non-medical from Panjab University, Chandigarh in 2015 and his Master's in Organic Chemistry from Maharishi Markandeshwar University, Mullana, India in 2017. He is pursuing his PhD degree from Chaudhary Bansi Lal University, Bhiwani, India with Dr Mayank Kinger, Associate Professor, Chaudhary Bansi Lal University, Bhiwani, India. His current research interests are the synthesis of new biologically potent heterocycles (anti-cancer, anti-Alzheimer, anti-inflammatory
Priyanka Rani was born in Bhiwani district, Haryana, India. She received her BSc degree in 2015 from Maharshi Dayanand University, Rohtak, and her M.Sc degree in 2017 from Baba Mastnath University, Rohtak. Now she is continuing her study at Chaudhary Bansi Lal University with Dr Mayank Kinger, Associate Professor, Chaudhary Bansi Lal University, Bhiwani, India conducting research work. Her current research interest focuses on five or six-membered heterocycles with pharmaceutical potential such as anti-diabetic, anti-anxiety, anti-malarial, anti-inflammatory, anti-fungal activity
Deepak Kumar was born in the small village of Saniana of District Fatehabad of Haryana State and obtained his early education from the village. He obtained his BSc in 2004 from CRM Jat (PG) College, Hisar and his MSc in 2006 from Kurukshetra University, Kurukshetra, India. He then joined Jubilant Chemsys Ltd, Noida, as Research Associate and worked there for 2 years from 2006 to 2008. Then, he moved back to Kurukshetra University and Joined the research group of Professor Om Prakash for his PhD studies. He submitted his PhD thesis in 2012 and defended in 2013. He joined GDC Memorial College, Bahal, Bhiwani in 2012 and worked as Assistant Professor for 3 years. In 2015, he joined Chaudhary Bansi Lal University, Haryana as Assistant Professor and is working on the reactivity of hypervalent iodine reagents under different reaction conditions and their importance in different fields of science.
Mayank Kinger obtained his bachelor's degree in Medical Science from C.C.S. University, Meerut, India in 2000. He obtained his Master's in Organic Chemistry from C.C.S. University, Meerut, India in 2002. He received his PhD degree from Kurukshetra University, Kurukshetra, India in 2008 under the supervision of Prof. Om Prakash, Emeritus Professor, Kurukshetra University. He was a postdoctoral fellow at Korea Atomic Energy Research Institute, South Korea from 2010 to 2012. Then, he joined M.M. University, Mullana, Ambala, India. In 2018, he joined Chaudhary Bansi Lal University, Haryana as Associate Professor. His current research interests are synthesis of new biologically potent heterocycles (anti-cancer, anti-Alzheimer, anti-inflammatory, anti-bacterial, anti-fungal agents
etc.
Ginna Kumari was born and grew up in Charkhi Dadri district, Haryana, India. She obtained her bachelor's degree in 2013 from Maharshi Dayanand University, Rohtak, and her master's degree in chemistry in 2016 from Panjab University, Chandigarh, India. She is currently working with Dr Mayank Kinger, in the Department of Chemistry, Chaudhary Bansilal University, Haryana, India. Her research interest is the synthesis of novel heterocycles.
.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0009-0003-0852-6170
0009-0003-3170-289X
0000-0002-4269-0834
0009-0001-3463-0030
OpenAccessLink http://dx.doi.org/10.1039/d3ra04309f
PQID 2863431551
PQPubID 2047525
PageCount 26
ParticipantIDs proquest_journals_2863431551
crossref_primary_10_1039_D3RA04309F
rsc_primary_d3ra04309f
proquest_miscellaneous_2862200503
crossref_citationtrail_10_1039_D3RA04309F
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10478505
PublicationCentury 2000
PublicationDate 2023-09-05
PublicationDateYYYYMMDD 2023-09-05
PublicationDate_xml – month: 09
  year: 2023
  text: 2023-09-05
  day: 05
PublicationDecade 2020
PublicationPlace Cambridge
PublicationPlace_xml – name: Cambridge
PublicationTitle RSC advances
PublicationYear 2023
Publisher Royal Society of Chemistry
The Royal Society of Chemistry
Publisher_xml – name: Royal Society of Chemistry
– name: The Royal Society of Chemistry
References Delancey (D3RA04309F/cit42/1) 2020; 9
El-Mekabaty (D3RA04309F/cit46/1) 2020; 57
Magedov (D3RA04309F/cit21/1) 2007; 50
Kasmi-Mir (D3RA04309F/cit62/1) 2018; 11
Abadi (D3RA04309F/cit16a/1) 2003; 51
Builla (D3RA04309F/cit4/1) 2011; 1
Mathew (D3RA04309F/cit23/1) 2012; 2
Zhang (D3RA04309F/cit32/1) 2017; 127
Farghaly (D3RA04309F/cit25b/1) 2006; 11
Abadi (D3RA04309F/cit20/1) 2003; 51
Irgashev (D3RA04309F/cit107/1) 2021; 79
Bala (D3RA04309F/cit51/1) 2018; 55
Ozdemir (D3RA04309F/cit26/1) 2007; 42
El-Desoky (D3RA04309F/cit11/1) 2017; 2
Swami (D3RA04309F/cit50/1) 2016; 57
Pahutski (D3RA04309F/cit60/1) 2023; 79
Panneer (D3RA04309F/cit33/1) 2011; 1
Duguta (D3RA04309F/cit106/1) 2020; 50
Ziajahromi (D3RA04309F/cit7/1) 2016; 74
Pervaram (D3RA04309F/cit47/1) 2017; 87
Hu (D3RA04309F/cit89/1) 2015; 44
Datoussaid (D3RA04309F/cit71/1) 2020; 1
Gupton (D3RA04309F/cit74/1) 2008; 64
Benaamane (D3RA04309F/cit22b/1) 2008; 16
Abdelwahab (D3RA04309F/cit98/1) 2017; 49
Popov (D3RA04309F/cit58/1) 2019
Dong (D3RA04309F/cit102/1) 2005; 1
Enguehard-Gueiffier (D3RA04309F/cit87/1) 2007; 7
Hung (D3RA04309F/cit96/1) 2014; 86
Tang (D3RA04309F/cit2/1) 2008; 73
Naik (D3RA04309F/cit108/1) 2018; 5
Sathiyaseelan (D3RA04309F/cit52/1) 2016; 4
Tang (D3RA04309F/cit72/1) 2019; 40
Reddy (D3RA04309F/cit8/1) 2004; 52
Nagamallu (D3RA04309F/cit49/1) 2016; 26
Hu (D3RA04309F/cit31/1) 2017; 20
Fadavi (D3RA04309F/cit63/1) 2018; 21
Abdi (D3RA04309F/cit79/1) 2021
Chovatia (D3RA04309F/cit24/1) 2007; 71
Gao (D3RA04309F/cit109/1) 2017; 60
Prakash (D3RA04309F/cit75/1) 2005; 35
Bebernitz (D3RA04309F/cit17/1) 2001; 44
Kumar (D3RA04309F/cit40/1) 2018; M1011
Zhang (D3RA04309F/cit70/1) 2011; 76
Kumari (D3RA04309F/cit39/1) 2020; 57
Hafez (D3RA04309F/cit9/1) 2008; 43
Chung (D3RA04309F/cit100/1) 2021; 26
Flower (D3RA04309F/cit16b/1) 2003; 2
Farat (D3RA04309F/cit105/1) 2021; 152
AppiáReddy (D3RA04309F/cit82/1) 2011; 9
Tingle (D3RA04309F/cit10/1) 2003
Shetty (D3RA04309F/cit54/1) 2020; 30
Szabo (D3RA04309F/cit22a/1) 2008; 51
El-Gharably (D3RA04309F/cit37/1) 2022; 29
Husain (D3RA04309F/cit95/1) 2022; 34
Vilsmeier (D3RA04309F/cit3/1) 1927; 60
Vellalacheruvu (D3RA04309F/cit80/1) 2017; 3
Gilbert (D3RA04309F/cit19/1) 2006; 49
Katz (D3RA04309F/cit15/1) 1984; 21
Ahmad (D3RA04309F/cit6/1) 2016; 20
Keter (D3RA04309F/cit35/1) 2012; 25
Taber (D3RA04309F/cit92/1) 2011; 67
Al-Thakafy (D3RA04309F/cit84/1) 2022; 65
Mamatha (D3RA04309F/cit57/1) 2022; 41
Rajput (D3RA04309F/cit59/1) 2015; 12
Aparna (D3RA04309F/cit61/1) 2019; 89
Aeluri (D3RA04309F/cit85/1) 2015; 100
Koval (D3RA04309F/cit69/1) 2017; 91
Abdelwahab (D3RA04309F/cit97/1) 2016; 48
Chami (D3RA04309F/cit103/1) 2017; 8
Al-Lami (D3RA04309F/cit86/1) 2018; 10
Mohammed (D3RA04309F/cit68/1) 2022; 76
Marella (D3RA04309F/cit77/1) 2013; 21
Derry (D3RA04309F/cit13/1) 2010; 8
Antuf’eva (D3RA04309F/cit88/1) 2018; 88
Saudi (D3RA04309F/cit29/1) 2016; 121
Sener (D3RA04309F/cit27/1) 2002; 39
Saoud (D3RA04309F/cit101/1) 2020; 10
Eftekhari-Sis (D3RA04309F/cit93/1) 2010; 47
Sun (D3RA04309F/cit81/1) 2018
Quiroga (D3RA04309F/cit91/1) 2010; 51
Zaman (D3RA04309F/cit83/1) 2019; 1180
El-Assiery (D3RA04309F/cit90/1) 2004; 54
Mphahlele (D3RA04309F/cit78/1) 2019; 17
Hashem (D3RA04309F/cit25a/1) 2007; 42
Potopnyk (D3RA04309F/cit48/1) 2017; 53
Sangwan (D3RA04309F/cit34/1) 1980; 19
Tadtong (D3RA04309F/cit110/1) 2016; 15
Scriven (D3RA04309F/cit67/1) 2000
Fahmy (D3RA04309F/cit28/1) 2002; 335
Cohn (D3RA04309F/cit1/1) 1991; 2
Pawar (D3RA04309F/cit5/1) 2020
Noh (D3RA04309F/cit104/1) 2020
Marmor (D3RA04309F/cit12/1) 1999; 44
Mishra (D3RA04309F/cit38/1) 2020; 9
Farghaly (D3RA04309F/cit25c/1) 2006
Shelkovnikov (D3RA04309F/cit66/1) 2019; 55
Alnufaie (D3RA04309F/cit44/1) 2020; 25
Nashaan (D3RA04309F/cit56/1) 2023; 7
Faraj (D3RA04309F/cit94/1) 2022; 2398
Raghavendra (D3RA04309F/cit41/1) 2015; 7
Manvar (D3RA04309F/cit30/1) 2015; 90
Bhat (D3RA04309F/cit55/1) 2016; 6
Hon (D3RA04309F/cit43/1) 2020; 57
Padalkar (D3RA04309F/cit45/1) 2016; 53
Barman (D3RA04309F/cit64/1) 2015; 51
Puljak (D3RA04309F/cit14/1) 2017; 5
Chamberlain (D3RA04309F/cit18/1) 2010; 58
Zarei (D3RA04309F/cit73/1) 2017; 49
Abd Allah (D3RA04309F/cit53/1) 2015; 45
Küçükgüzel (D3RA04309F/cit36/1) 2015; 97
Al-Dmour (D3RA04309F/cit65/1) 2021; 8
Gonçalves (D3RA04309F/cit99/1) 2018; 9
Zarei (D3RA04309F/cit76/1) 2017; 43
References_xml – volume: 10
  start-page: 3344
  year: 2018
  ident: D3RA04309F/cit86/1
  publication-title: Sci. Res.
– volume: 54
  start-page: 143
  year: 2004
  ident: D3RA04309F/cit90/1
  publication-title: Acta Pharm.
– volume: 51
  start-page: 869
  year: 2015
  ident: D3RA04309F/cit64/1
  publication-title: Chem. Heterocycl. Compd.
  doi: 10.1007/s10593-015-1789-z
– volume: 100
  start-page: 18
  year: 2015
  ident: D3RA04309F/cit85/1
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2015.05.037
– volume: 8
  start-page: 4182
  year: 2017
  ident: D3RA04309F/cit103/1
  publication-title: J. Mater. Environ. Sci.
– volume: 51
  start-page: 838
  year: 2003
  ident: D3RA04309F/cit16a/1
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.51.838
– volume: 6
  start-page: 59375
  year: 2016
  ident: D3RA04309F/cit55/1
  publication-title: RSC Adv.
  doi: 10.1039/C6RA06093E
– start-page: 1
  year: 2003
  ident: D3RA04309F/cit10/1
  publication-title: Rev. Environ. Contam. Toxicol.
– volume: 25
  start-page: 9
  year: 2012
  ident: D3RA04309F/cit35/1
  publication-title: BioMetals
  doi: 10.1007/s10534-011-9496-4
– volume: 79
  start-page: 1743
  year: 2023
  ident: D3RA04309F/cit60/1
  publication-title: Pest Manage. Sci.
  doi: 10.1002/ps.7349
– volume: 9
  start-page: 10
  year: 2018
  ident: D3RA04309F/cit99/1
  publication-title: Proceedings (MDPI)
– volume: 51
  start-page: 838
  year: 2003
  ident: D3RA04309F/cit20/1
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.51.838
– volume: 74
  start-page: 2253
  year: 2016
  ident: D3RA04309F/cit7/1
  publication-title: Water Sci. Technol.
  doi: 10.2166/wst.2016.414
– volume: 11
  start-page: 76
  year: 2006
  ident: D3RA04309F/cit25b/1
  publication-title: Arkivoc
  doi: 10.3998/ark.5550190.0007.b07
– volume: 1
  start-page: 1
  year: 2020
  ident: D3RA04309F/cit71/1
  publication-title: Chem. Process.
– volume: 48
  start-page: 2881
  year: 2016
  ident: D3RA04309F/cit97/1
  publication-title: Synthesis
  doi: 10.1055/s-0035-1561459
– volume: 49
  start-page: 355
  year: 2017
  ident: D3RA04309F/cit73/1
  publication-title: Org. Prep. Proced. Int.
  doi: 10.1080/00304948.2017.1342511
– start-page: 2078
  year: 2018
  ident: D3RA04309F/cit81/1
  publication-title: Eur. J. Org. Chem.
  doi: 10.1002/ejoc.201800249
– volume: 57
  start-page: 1692
  year: 2020
  ident: D3RA04309F/cit43/1
  publication-title: J. Heterocycl. Chem.
  doi: 10.1002/jhet.3894
– volume: 88
  start-page: 1103
  year: 2018
  ident: D3RA04309F/cit88/1
  publication-title: Russ. J. Gen. Chem.
  doi: 10.1134/S1070363218060099
– volume: 7
  start-page: 361
  year: 2015
  ident: D3RA04309F/cit41/1
  publication-title: J. Chem. Pharm. Res.
– volume: 50
  start-page: 5183
  year: 2007
  ident: D3RA04309F/cit21/1
  publication-title: J. Med. Chem.
  doi: 10.1021/jm070528f
– volume: 2
  start-page: 179
  year: 2003
  ident: D3RA04309F/cit16b/1
  publication-title: Nat. Rev. Drug. Discov.
  doi: 10.1038/nrd1034
– volume: 5
  start-page: 21498
  year: 2018
  ident: D3RA04309F/cit108/1
  publication-title: Mater. Today: Proc.
  doi: 10.1016/j.matpr.2018.06.560
– volume: 86
  start-page: 420
  year: 2014
  ident: D3RA04309F/cit96/1
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2014.09.001
– volume: 16
  start-page: 3059
  year: 2008
  ident: D3RA04309F/cit22b/1
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2007.12.033
– volume: 35
  start-page: 2819
  year: 2005
  ident: D3RA04309F/cit75/1
  publication-title: Synth. Commun.
  doi: 10.1080/00397910500290573
– volume: 1180
  start-page: 227
  year: 2019
  ident: D3RA04309F/cit83/1
  publication-title: J. Mol. Struct.
  doi: 10.1016/j.molstruc.2018.11.030
– volume: 1
  start-page: 126
  year: 2011
  ident: D3RA04309F/cit33/1
  publication-title: Afr. J. Chem. Educ.
– volume: 67
  start-page: 7195
  year: 2011
  ident: D3RA04309F/cit92/1
  publication-title: Tetrahedron
  doi: 10.1016/j.tet.2011.06.040
– volume: 29
  start-page: 1
  year: 2022
  ident: D3RA04309F/cit37/1
  publication-title: J. Polym. Res.
  doi: 10.1007/s10965-021-02672-1
– volume: 8
  start-page: 128
  year: 2021
  ident: D3RA04309F/cit65/1
  publication-title: Int. J. Adv. Appl. Sci.
  doi: 10.21833/ijaas.2021.06.015
– volume: 21
  start-page: 1
  year: 2013
  ident: D3RA04309F/cit77/1
  publication-title: Saudi Pharm. J.
  doi: 10.1016/j.jsps.2012.03.002
– volume: 121
  start-page: 158
  year: 2016
  ident: D3RA04309F/cit29/1
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2016.05.043
– volume: 20
  start-page: 577
  year: 2016
  ident: D3RA04309F/cit6/1
  publication-title: J. Saudi Chem. Soc.
  doi: 10.1016/j.jscs.2014.12.004
– volume: 44
  start-page: 645
  year: 2015
  ident: D3RA04309F/cit89/1
  publication-title: Chem. Lett.
  doi: 10.1246/cl.150133
– volume: 5
  start-page: 1
  year: 2017
  ident: D3RA04309F/cit14/1
  publication-title: Cochrane Database Syst. Rev.
– start-page: 353
  year: 2020
  ident: D3RA04309F/cit5/1
  publication-title: Res. Int. Advancem. Plant Sci.
– volume: 41
  start-page: 100930
  year: 2022
  ident: D3RA04309F/cit57/1
  publication-title: Chem. Data Collect.
  doi: 10.1016/j.cdc.2022.100930
– volume: 43
  start-page: 1909
  year: 2017
  ident: D3RA04309F/cit76/1
  publication-title: Res. Chem. Intermed.
  doi: 10.1007/s11164-016-2738-x
– start-page: 1136
  year: 2020
  ident: D3RA04309F/cit104/1
  publication-title: Molbank
  doi: 10.3390/M1136
– volume: 43
  start-page: 1971
  year: 2008
  ident: D3RA04309F/cit9/1
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2007.12.006
– volume: M1011
  start-page: 1
  year: 2018
  ident: D3RA04309F/cit40/1
  publication-title: Molbank
– volume: 40
  start-page: 243
  year: 2019
  ident: D3RA04309F/cit72/1
  publication-title: Bull. Korean Chem. Soc.
  doi: 10.1002/bkcs.11673
– volume: 9
  start-page: 650
  year: 2020
  ident: D3RA04309F/cit42/1
  publication-title: Antibiotics
  doi: 10.3390/antibiotics9100650
– volume: 73
  start-page: 8317
  year: 2008
  ident: D3RA04309F/cit2/1
  publication-title: J. Org. Chem.
  doi: 10.1021/jo801492k
– volume: 65
  start-page: 1
  year: 2022
  ident: D3RA04309F/cit84/1
  publication-title: Egypt. J. Chem.
– volume: 58
  start-page: 6895
  year: 2010
  ident: D3RA04309F/cit18/1
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/jf100872f
– volume: 9
  start-page: 1738
  year: 2020
  ident: D3RA04309F/cit38/1
  publication-title: World J. Pharm. Pharm. Sci.
– volume: 45
  start-page: 944
  year: 2015
  ident: D3RA04309F/cit53/1
  publication-title: Synth. Commun.
  doi: 10.1080/00397911.2014.994128
– volume: 2
  start-page: 1
  year: 2012
  ident: D3RA04309F/cit23/1
  publication-title: J. Am. Chem. Soc.
  doi: 10.9734/ACSJ/2012/1063
– volume: 39
  start-page: 869
  year: 2002
  ident: D3RA04309F/cit27/1
  publication-title: J. Heterocycl. Chem.
  doi: 10.1002/jhet.5570390503
– volume: 89
  start-page: 1202
  year: 2019
  ident: D3RA04309F/cit61/1
  publication-title: Russ. J. Gen. Chem.
  doi: 10.1134/S1070363219060161
– volume: 7
  start-page: 888
  year: 2007
  ident: D3RA04309F/cit87/1
  publication-title: Mini-Rev. Med. Chem.
  doi: 10.2174/138955707781662645
– volume: 64
  start-page: 5246
  year: 2008
  ident: D3RA04309F/cit74/1
  publication-title: Tetrahedron
  doi: 10.1016/j.tet.2008.03.038
– volume: 90
  start-page: 497
  year: 2015
  ident: D3RA04309F/cit30/1
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2014.11.042
– volume: 127
  start-page: 275
  year: 2017
  ident: D3RA04309F/cit32/1
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2016.12.059
– volume: 44
  start-page: 2601
  year: 2001
  ident: D3RA04309F/cit17/1
  publication-title: J. Med. Chem.
  doi: 10.1021/jm010032c
– volume: 12
  start-page: 1689
  year: 2015
  ident: D3RA04309F/cit59/1
  publication-title: World J. Pharm. Res.
– volume: 71
  start-page: 713
  year: 2007
  ident: D3RA04309F/cit24/1
  publication-title: J. Serb. Chem. Soc.
  doi: 10.2298/JSC0607713C
– volume: 9
  start-page: 1004
  year: 2011
  ident: D3RA04309F/cit82/1
  publication-title: Org. Biomol. Chem.
  doi: 10.1039/C0OB00771D
– volume: 60
  start-page: 119
  year: 1927
  ident: D3RA04309F/cit3/1
  publication-title: Ber. Dtsch. Chem. Ges.
  doi: 10.1002/cber.19270600118
– volume: 42
  start-page: 934
  year: 2007
  ident: D3RA04309F/cit25a/1
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2006.12.032
– volume: 7
  start-page: 267
  year: 2023
  ident: D3RA04309F/cit56/1
  publication-title: Chem. Methodol.
– volume: 335
  start-page: 213
  year: 2002
  ident: D3RA04309F/cit28/1
  publication-title: Arch. Pharm.
  doi: 10.1002/1521-4184(200205)335:5<213::AID-ARDP213>3.0.CO;2-H
– volume: 55
  start-page: 1504
  year: 2019
  ident: D3RA04309F/cit66/1
  publication-title: Russ. J. Org. Chem.
  doi: 10.1134/S1070428019100087
– volume: 57
  start-page: 1346
  year: 2016
  ident: D3RA04309F/cit50/1
  publication-title: Tetrahedron Lett.
  doi: 10.1016/j.tetlet.2016.02.045
– volume: 51
  start-page: 2928
  year: 2010
  ident: D3RA04309F/cit91/1
  publication-title: Tetrahedron Lett.
  doi: 10.1016/j.tetlet.2010.03.117
– volume: 21
  start-page: 487
  year: 1984
  ident: D3RA04309F/cit15/1
  publication-title: Pharmacol. Biochem. Behav.
  doi: 10.1016/S0091-3057(84)80027-1
– volume: 30
  start-page: 123
  year: 2020
  ident: D3RA04309F/cit54/1
  publication-title: Indian J. Heterocycl. Chem.
– volume: 47
  start-page: 463
  year: 2010
  ident: D3RA04309F/cit93/1
  publication-title: J. Heterocycl. Chem.
  doi: 10.1002/jhet.338
– volume: 26
  start-page: 2907
  year: 2021
  ident: D3RA04309F/cit100/1
  publication-title: Molecules
  doi: 10.3390/molecules26102907
– volume: 15
  start-page: 2619
  year: 2016
  ident: D3RA04309F/cit110/1
  publication-title: Trop. J. Pharm. Res.
  doi: 10.4314/tjpr.v15i12.12
– volume: 26
  start-page: 690
  year: 2016
  ident: D3RA04309F/cit49/1
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2015.11.038
– volume: 51
  start-page: 142
  year: 2008
  ident: D3RA04309F/cit22a/1
  publication-title: J. Med. Chem.
  doi: 10.1021/jm070821f
– volume: 2
  start-page: 777
  year: 1991
  ident: D3RA04309F/cit1/1
  publication-title: Compr. Org. Synth.
  doi: 10.1016/B978-0-08-052349-1.00049-4
– volume: 11
  start-page: 183
  year: 2018
  ident: D3RA04309F/cit62/1
  publication-title: Int. J. ChemTech Res.
– volume: 57
  start-page: 796
  year: 2020
  ident: D3RA04309F/cit39/1
  publication-title: J. Heterocycl. Chem.
  doi: 10.1002/jhet.3824
– volume: 76
  start-page: 2880
  year: 2011
  ident: D3RA04309F/cit70/1
  publication-title: J. Org. Chem.
  doi: 10.1021/jo101949y
– volume: 50
  start-page: 1641
  year: 2020
  ident: D3RA04309F/cit106/1
  publication-title: Synth. Commun.
  doi: 10.1080/00397911.2020.1750033
– volume: 4
  start-page: 172
  year: 2016
  ident: D3RA04309F/cit52/1
  publication-title: Indian J. Adv. Chem. Sci.
– volume: 2
  start-page: 635
  year: 2017
  ident: D3RA04309F/cit11/1
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 79
  start-page: 153297
  year: 2021
  ident: D3RA04309F/cit107/1
  publication-title: Tetrahedron Lett.
  doi: 10.1016/j.tetlet.2021.153297
– volume: 17
  start-page: 2204
  year: 2019
  ident: D3RA04309F/cit78/1
  publication-title: Org. Biomol. Chem.
  doi: 10.1039/C8OB03040E
– volume: 57
  start-page: 1123
  year: 2020
  ident: D3RA04309F/cit46/1
  publication-title: J. Heterocycl. Chem.
  doi: 10.1002/jhet.3849
– volume: 21
  start-page: 9
  year: 2018
  ident: D3RA04309F/cit63/1
  publication-title: C. R. Chim.
  doi: 10.1016/j.crci.2017.12.001
– start-page: 137
  year: 2006
  ident: D3RA04309F/cit25c/1
  publication-title: Arkivoc
  doi: 10.3998/ark.5550190.0007.a17
– volume: 19
  start-page: 297
  year: 1980
  ident: D3RA04309F/cit34/1
  publication-title: Indian J. Chem.
– volume: 91
  start-page: 246
  year: 2017
  ident: D3RA04309F/cit69/1
  publication-title: Russ. J. Phys. Chem. A
  doi: 10.1134/S0036024417020182
– volume: 53
  start-page: 1347
  year: 2016
  ident: D3RA04309F/cit45/1
  publication-title: J. Heterocycl. Chem.
  doi: 10.1002/jhet.1506
– volume: 10
  start-page: 487
  year: 2020
  ident: D3RA04309F/cit101/1
  publication-title: Technology
– volume: 1
  start-page: 85
  year: 2005
  ident: D3RA04309F/cit102/1
  publication-title: Synthesis
– volume: 53
  start-page: 62
  year: 2017
  ident: D3RA04309F/cit48/1
  publication-title: Russ. J. Org. Chem.
  doi: 10.1134/S1070428017010110
– volume: 25
  start-page: 2758
  year: 2020
  ident: D3RA04309F/cit44/1
  publication-title: Molecules
  doi: 10.3390/molecules25122758
– volume: 2398
  start-page: 30004
  year: 2022
  ident: D3RA04309F/cit94/1
  publication-title: AIP Conf. Proc.
  doi: 10.1063/5.0093601
– start-page: 1
  year: 2019
  ident: D3RA04309F/cit58/1
  publication-title: Org. Chem.
– volume: 52
  start-page: 307
  year: 2004
  ident: D3RA04309F/cit8/1
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.52.307
– volume: 34
  start-page: 102023
  year: 2022
  ident: D3RA04309F/cit95/1
  publication-title: J. King Saud Univ., Sci.
  doi: 10.1016/j.jksus.2022.102023
– start-page: 1
  year: 2021
  ident: D3RA04309F/cit79/1
  publication-title: J. Chem.
  doi: 10.1155/2021/2408006
– volume: 3
  start-page: 52
  year: 2017
  ident: D3RA04309F/cit80/1
  publication-title: Org. Med. Chem. Int. J.
– volume: 8
  start-page: 1
  year: 2010
  ident: D3RA04309F/cit13/1
  publication-title: Cochrane Database Syst. Rev.
– start-page: 641
  year: 2000
  ident: D3RA04309F/cit67/1
  publication-title: Kirk-Othmer Encycl. Chem. Technol.
– volume: 20
  start-page: 255
  year: 2017
  ident: D3RA04309F/cit31/1
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2017.04.002
– volume: 76
  start-page: 2615
  year: 2022
  ident: D3RA04309F/cit68/1
  publication-title: Chem. Pap.
  doi: 10.1007/s11696-022-02066-7
– volume: 42
  start-page: 373
  year: 2007
  ident: D3RA04309F/cit26/1
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2006.09.006
– volume: 152
  start-page: 95
  year: 2021
  ident: D3RA04309F/cit105/1
  publication-title: Monatsh. Chem.
  doi: 10.1007/s00706-020-02733-z
– volume: 49
  start-page: 6027
  year: 2006
  ident: D3RA04309F/cit19/1
  publication-title: J. Med. Chem.
  doi: 10.1021/jm060499t
– volume: 44
  start-page: 153
  year: 1999
  ident: D3RA04309F/cit12/1
  publication-title: Surv. Ophthalmol.
  doi: 10.1016/S0039-6257(99)00079-X
– volume: 87
  start-page: 2454
  year: 2017
  ident: D3RA04309F/cit47/1
  publication-title: Russ. J. Gen. Chem.
  doi: 10.1134/S1070363217100280
– volume: 55
  start-page: 2507
  year: 2018
  ident: D3RA04309F/cit51/1
  publication-title: J. Heterocycl. Chem.
  doi: 10.1002/jhet.3282
– volume: 97
  start-page: 786
  year: 2015
  ident: D3RA04309F/cit36/1
  publication-title: Eur. J. Med. Chem.
  doi: 10.1016/j.ejmech.2014.11.059
– volume: 49
  start-page: 2971
  year: 2017
  ident: D3RA04309F/cit98/1
  publication-title: Synthesis
  doi: 10.1055/s-0036-1588992
– volume: 60
  start-page: 819
  year: 2017
  ident: D3RA04309F/cit109/1
  publication-title: Sci. China Mater.
  doi: 10.1007/s40843-017-9084-x
– volume: 1
  start-page: 1
  year: 2011
  ident: D3RA04309F/cit4/1
  publication-title: Mod. Heterocycl. Chem.
SSID ssj0000651261
Score 2.4647446
SecondaryResourceType review_article
Snippet The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier-Haack (V....
The aim of this review is to encapsulate the synthetic protocols and medicinal aspects of a wide range of heterocyclic compounds using the Vilsmeier–Haack (V....
SourceID pubmedcentral
proquest
crossref
rsc
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 2664
SubjectTerms Anticonvulsants
Chemical synthesis
Chemistry
Heterocyclic compounds
Organic chemistry
Precursors
Reagents
Title Unravelling the synthetic and therapeutic aspects of five, six and fused heterocycles using Vilsmeier-Haack reagent
URI https://www.proquest.com/docview/2863431551
https://www.proquest.com/docview/2862200503
https://pubmed.ncbi.nlm.nih.gov/PMC10478505
Volume 13
WOSCitedRecordID wos001058492700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2046-2069
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000651261
  issn: 2046-2069
  databaseCode: DOA
  dateStart: 20170101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2046-2069
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000651261
  issn: 2046-2069
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LjtMwFLU6AxJsEK8RhaEygg0qFZk87eWowzALOqqYh7qrHMeh0XTSqmlG7QbxD3wDP8aXcH0TOy2wACQ2aZs4ruR7bN9rH59LyKskdgSXseyliZA9X3epWOgDzNILVOqIVGCazssP0ekpG434sNX6Zs7C3EyjPGerFZ__V1PDPTC2Pjr7F-a2lcIN-A5GhyuYHa5_ZPiLXGcUqqS2tVdZrHP4MLqsG-etugKPWSKXI4VBT7d2ka2wWFoW4IlONFdmJteaOdctcVXhMpsW1wrmUsOS8E6EkFdd8D0_GQ6N0fs-6xuKgXXc-xMxwRQD3YG4Xtop4UjvSVT7_2dlotS82X7ClFPd4SJbi_zKvoDMcHzyPsurBOBm7cL1kJwVWLTpnlCtkhiKKlJQ6kR31QyFQ6ELUTwYuUrqYsdtbwOflUSMGYXDsMppXE_p8LtaVvllvnA8LbeaeAuhtc942syKlqs4HPRRwijQSrm33CjgevAcfG6W8sCLO4BA1IjfevxtU-G2u9PEMD8zcHcWJuEMOjbn98m9OiKhhxWSHpCWyh-SO7Z9HpFyA1EU8EMtoihAhW4gitaIorOUakS9oYAnLIR4opt4oognavH0_ctXRBKtkfSYXBy_O--f9OpsHT0JTuGyJ3jCY1dxrtwkUuDIO8qXoYKezxUHP1m6MgxjN4R4VrBAOdJnQogg9BMufC4Sb4_s5rNcPSEUQhbGAq2zFAlfMR6LAz9hImCpCpiMnTZ5bRp1LGspe51RZTpGSoXHx0fex0M0wHGbvLRl55WAy29L7RvbjOu-XIxdFnrgX0NM0SYv7GNofL2nJnI1K7GM66KoUpuwLZvaf9MC7ttP8myCQu4GV22yB-a3LzToefrvdT4jd5set092l4tSPSe35c0yKxYdshONWAcXoDoI5h_y19eH
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Unravelling+the+synthetic+and+therapeutic+aspects+of+five%2C+six+and+fused+heterocycles+using+Vilsmeier%E2%80%93Haack+reagent&rft.jtitle=RSC+advances&rft.au=Chahal%2C+Mamta&rft.au=Dhillon%2C+Sudeep&rft.au=Rani%2C+Priyanka&rft.au=Kumari%2C+Ginna&rft.date=2023-09-05&rft.pub=The+Royal+Society+of+Chemistry&rft.eissn=2046-2069&rft.volume=13&rft.issue=38&rft.spage=26604&rft.epage=26629&rft_id=info:doi/10.1039%2Fd3ra04309f&rft.externalDocID=PMC10478505
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2046-2069&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2046-2069&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2046-2069&client=summon